The first Intel (NASDAQ: INTC ) Bay Trail benchmarks are out, and it's looking like the ARM Holdings (NASDAQ: ARMH ) competition should be a little concerned. Bay Trail is Intel's upcoming Atom processor that will eventually make its way into a slew of premium smartphones and tablets later this year.
According to data from an AnTuTu Benchmark, which measures the performance of Google Android devices, a quad-core 1.1 GHz Bay Trail-T tablet processor outperformed the fastest ARM competitor, a 2.3 GHz quad-core Qualcomm Snapdragon 800 processor, by 44%. Also, the Bay Trail-T's benchmark was performed at about half its expected clock speed of 2.1 GHz, implying that a fully clocked Bay Trail-T processor would absolutely smoke the fastest ARM competitor.
Pack your bags
If Bay Trail's numbers prove to be indicative of real-world performance, there is little, if any incentive for Microsoft (NASDAQ: MSFT ) to keep supporting Windows RT. Windows RT has been responsible for mass consumer confusion, and it lacks the backwards-compatibility with legacy Windows applications since it runs on ARM architecture. If Intel's products can outperform ARM and match its power consumption, Microsoft would effectively have the green light to eliminate Windows RT altogether. This would allow Microsoft to further streamline the Windows 8 user experience and could potentially translate into improved reception. Unfortunately, from ARM's perspective, the Windows on ARM opportunity may be gone before it's arrived.
Top 5 Financial Stocks To Invest In 2015: Softbank Corp (SFTBF)
SOFTBANK CORP. is a Japan-based company that provides digital information services. The Company has six business segments. The Mobile Communication segment provides cellular phone services and sells attached cellular phone terminals. The Broadband and Infrastructure segment provides high-speed Internet access services, Internet protocol (IP) phone service, and contents. The Fixed Communication segment provides transmission services for audio and data, as well as exclusive line and data center services. The Internet Culture segment is engaged in the Internet advertising, broadband portal and auction businesses. The Electronic Commerce (E-Commerce) segment sells personal computers (PCs), peripheral devices and software for PC use, as well as provides business-to-business and business-to-customer e-commerce services. The Others segment is involved in the broadcasting media, technology service, media marketing and overseas fund businesses.
Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks rose Wednesday after a lower open, managing solid gains with most other Asian markets were closed for the Christmas holiday. The Nikkei Stock Average (JP:NIK) climbed 0.8% to 16,009.99, its first close above the 16,000 level since late 2007. The broader Topix ended with a more modest 0.1% rise. Seven & I Holdings Co. (JP:3382) (SVNDF) , operators of the 7-Eleven convenience-store chain, rose 1.5% as a Nikkei Asian Review report said it planned to pay about 楼5 billion yen to purchase nearly half of Bals, which runs home-and-kitchen-furnishings retailer Francfranc. Chip maker Renesas Electronics Corp. (JP:6723) (RNECY) was a strong performer, rallying 6.5% after suffering a sizeable drop in the previous session. On the downside, shares of Softbank Corp. (JP:9984) (SFTBF) fell 0.5%, after a separate article in the Nikkei saying that previously reported plans by the firm to buy T-Mobile US Inc. (TMUS) through its newly acquired Sprint (S) unit would value the transaction at more than 2 trillion yen ($19 billion) and would take place as early as next spring. Auto-maker stocks were mostly higher after trading mixed following the release of Japanese car-sales data for November. Toyota Motor Corp. (JP:7203) (TM) added 0.2%, Honda Motor Co. (JP:7267)
- [By Damian Illia]
Furthermore, Nippon recently gained access to the iPhone, which earns the firm the opportunity to reverse its share losses in the youth market. Earlier, market share on the wireless side had declined in favor of competitor Softbank Corp. (SFTBF), which had exclusive rights to sell Apple Inc. (AAPL)�� iPhone in Japan.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks rose Wednesday after a lower open, with action quiet as most other Asian markets were closed for the Christmas holiday. The Nikkei Stock Average (JP:NIK) gained 0.4% to 15,948.04, but with the broader Topix 0.4% lower. Seven & I Holdings Co. (JP:3382) (SVNDF) , operators of the 7-Eleven convenience-store chain, rose 1.3% as a Nikkei Asian Review report said it planned to pay about 楼5 billion yen to purchase nearly half of Bals, which runs home-and-kitchen-furnishings retailer Francfranc. Chip maker Renesas Electronics Corp. (JP:6723) (RNECY) was a strong performer, rallying 5.3% after suffering a sizeable drop in the previous session. On the downside, shares of Softbank Corp. (JP:9984) (SFTBF) fell 0.9%, after a separate article in the Nikkei saying that previously reported plans by the firm to buy T-Mobile US Inc. (TMUS) through its newly acquired Sprint (S) unit would value the transaction at more than 2 trillion yen ($19 billion) and would take place as early as next spring. Auto-maker stocks were mixed after the release of Japanese car-sales data for November, with Toyota Motor Corp. (JP:7203) (TM) flat, Honda Motor Co. (JP:7267) (HMC) down 0.4%, Mitsubishi Motors
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- With the yen holding on to its gains and investors cautious as earnings season kicks off, Japanese stocks slid lower Friday after closing the previous day with some late-session gains. The Nikkei Stock Average (JP:NIK) fell 0.9% to 14,358.28, with the Topix down 0.8%, as the dollar bought 97.36 yen, little changed from 24 hours earlier. The relatively strong yen weighed on some names with high global exposure, as Sharp Corp. (JP:6753) (SHCAF) lost 1%, Pioneer Corp. (JP:6773) (PNCOF) dropped 1.6%, and Bridgestone Corp. (JP:5108) (BRDCF) fell 1.2%. An outlook cut from Canon Inc. (JP:7751) (CAJ) helped send its shares down 1%, while rival Nikon Corp. (JP:7731) (NINOF) lost 1.8%, though Olympus Corp. (JP:7733) (OCPNF) gained 1%. Telecoms were weak, with Softbank Corp. (JP:9984) (SFTBF) falling 2.5%, KDDI Corp. (JP:9433) (KDDIF) down 1.7%, and NTT DoCoMo Inc. (JP:9437) (NTDMF)
10 Best High Tech Stocks To Buy For 2014: ProLogis(PLD)
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, management, and leasing of industrial distribution and retail properties. It was previously known as Security Capital Investment Trust. Prologis Inc. was formed in 1991 and is based in San Francisco, California with an additional office in Denver, Colorado.
Advisors' Opinion:- [By Eric Volkman]
Prologis (NYSE: PLD ) has announced that it will sell 31 million new pieces of itself. That's the number of common shares it will float in an upcoming, underwritten public stock offering. The price of the shares will be $41.60 apiece, and the company's underwriters have been granted a 30-day purchase option for up to an additional 4.65 million shares to cover overallotments, if any.
- [By Ben Levisohn]
But the S&P 500′s biggest losers show the kind of carnage long predicted by those fearful of higher yields. How’s this for evidence: Real-estate investment trusts,�whose yields look more paltry with every tick higher in the 10-year Treasury, made up half of the top-10 losers. Prologis (PLD) fell 8.4% to $35.08, the Macerich Co. (MAC) dropped 8.2% to $56.72 and Health Care REIT (HCN) was off 8.1% at $58.57.
- [By Oliver Pursche]
As the real-estate crisis unfolded in 2008, Mr. Moghadam acted boldly and intelligently, taking advantage of opportunities around the world and eventually merging AMB with ProLogis (PLD) �in 2011 to create the current, a company who�� stock, since the bottom of the crisis in 2009, has outperformed the S&P 500.
10 Best High Tech Stocks To Buy For 2014: Boyd Gaming Corporation(BYD)
Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company in the United States. As of December 31, 2011, the company owned and operated 1,042,787 square feet of casino space, containing approximately 25,973 slot machines, 655 table games, and 11,418 hotel rooms. It also owned and operated 16 gaming entertainment properties located in Nevada, Illinois, Louisiana, Mississippi, Indiana, and New Jersey. In addition, the company owns and operates a pari-mutuel jai-alai facility located in Dania Beach, Florida, as well as a travel agency in Hawaii. Further, it holds a 50% controlling interest in the limited liability company that operates Borgata Hotel Casino and Spa in Atlantic City, New Jersey. Boyd Gaming Corporation was founded in 1988 and is headquartered in Las Vegas, Nevada.
Advisors' Opinion:- [By Seth Jayson]
Boyd Gaming (NYSE: BYD ) reported earnings on April 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Boyd Gaming met expectations on revenues and beat expectations on earnings per share.
10 Best High Tech Stocks To Buy For 2014: Jacksonville Bancorp Inc. (JXSB)
Jacksonville Bancorp, Inc. operates as the holding company for Jacksonville Savings Bank that provides various banking products and services in Illinois. Its deposit products include interest-bearing and non interest-bearing checking accounts, savings accounts, money market accounts, term certificate accounts, individual retirement accounts, and certificates of deposit. The company?s loan portfolio comprises one-to four-family mortgage loans; commercial and agricultural real estate, and multi-family residential real estate loans; commercial and agricultural business loans; and consumer loans, such as home equity loans and lines of credit, and automobile loans. It operates through its main office, as well as through six branches located in Jacksonville, Virden, Litchfield, Chapin, and Concord, Illinois. The company was founded in 1916 and is based in Jacksonville, Illinois. Jacksonville Bancorp, Inc. is a subsidiary of Jacksonville Bancorp, MHC.
Advisors' Opinion:- [By Traders Reserve]
Jacksonville Bancorp (JXSB), based in Illinois, owns a loan portfolio comprised of one-to four-family residential real estate; commercial and agricultural real estate; multi-family residential real estate loans; commercial and agricultural business loans; home equity loans and lines of credit.
10 Best High Tech Stocks To Buy For 2014: Globecomm Systems Inc. (GCOM)
Globecomm Systems Inc. engages in the provision of satellite-based network solutions to government, communications service providers, commercial enterprises, and media and content broadcasters in the United States, Europe, South America, Africa, the Middle East, and Asia. It offers access products for providing data, voice, and video transport services; hosted application products for back office applications services; and professional services, including advisory and consulting services. The company also provides life cycle support services comprising installation, network monitoring, help desk, maintenance, and professional engineering services that supports access and hosted products; and infrastructure solutions, such as design, engineering, and installation of ground segment systems and networks, which are used in communications and media delivery networks. In addition, it offers fixed satellite terminals under the Summit brand; transportable satellite terminals under the Explorer brand; and network management systems to manage, monitor, and control networks under the AxxSys brand name, as well as systems design and integration products. The company was founded in 1994 and is headquartered in Hauppauge, New York.
Advisors' Opinion:- [By Rich Smith]
Instead, the winners who will compete among themselves to fulfill the $45 million firm-fixed-price, multiple-award, indefinite-delivery/indefinite-quantity contract include privately held Bluewater Communications Group LLC, small-cap Globecomm Systems (NASDAQ: GCOM ) , and TVC Communications LLC, of Annville, Penn., a small subsidiary of larger electronics distributor WESCO International (NYSE: WCC ) . All three will now be competing against each other to win the Pentagon's business on individual task orders for the Cisco and other HD equipment on order.
10 Best High Tech Stocks To Buy For 2014: Box Ships Inc.(TEU)
Box Ships Inc. owns and operates containerships. As of August 16, 2011, it operated a fleet of 7 containerships with a total carrying capacity of 33,237 twenty-foot equivalent units. The company was founded in 2010 and is based in Athens, Greece.
Advisors' Opinion:- [By Monica Gerson]
Box Ships (NYSE: TEU) slipped 18.49% to $1.94 after the company priced 5 million units at $2.05 per unit.
China Auto Logistic (NASDAQ: CALI) shares dropped 9.06% to $3.17 after the company announced 2013 results. China Auto Logistic posted its net income of $524,260, or $0.14 per share.
- [By Monica Gerson]
Box Ships (NYSE: TEU) shares fell 20.38% to reach a new 52-week low of $1.90 after the company priced 5 million units at $2.05 per unit.
Toyota Motor (NYSE: TM) shares reached a new 52-week low of $104.90. Toyota shares have dropped 4.90% over the past 52 weeks, while the S&P 500 index has gained 17.50% in the same period.
10 Best High Tech Stocks To Buy For 2014: Mast Therapeutics Inc (MSTX)
Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., incorporated in December 1995, is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease. As of December 31, 2011, the Company also is developing ANX-514, a detergent-free formulation of the chemotherapy drug docetaxel. The Company offers ANX-188 (purified poloxamer 188), ANX-514 (docetaxel for injectable emulsion) and Exelbine (vinorelbine injectable emulsion). In April 2011, the Company acquired SynthRx, Inc. In February 2014, Mast Therapeutics Inc completed its acquisition of Aires Pharmaceuticals, Inc. Aires became a wholly-owned subsidiary of Mast Therapeutics.
ANX-188 (purified poloxamer 188)
ANX-188 is an aqueous solution of a purified form of poloxamer 188. Poloxamer 188 (P1880, is a nonionic, block copolymer that has been found to improve microvascular blood flow by reducing viscosity, particularly under low shear conditions, and by reducing adhesive frictional forces. The Company�� purified form of P188 (purified P188), which is the active ingredient in ANX-188, was designed to eliminate certain low molecular weight substances present in P188 (non-purified), which is primarily responsible for the moderate to moderately severe elevations in serum creatinine levels (acute renal dysfunction) observed in prior clinical studies of P188 (non-purified). Purified P188 has been evaluated in multiple clinical studies by a prior sponsor, including a 255-patient, phase III study.
ANX-514 (docetaxel for injectable emulsion)
ANX-514 is a detergent-free emulsion formulation of docetaxel, an intravenously-injected chemotherapy drug commonly used to treat solid tumors. Taxotere, a branded form! ulation of docetaxel, is approved to treat breast, non-small cell lung, prostate, gastric, and head and neck cancers. ANX-514 was designed to have clinically comparable release of docetaxel relative to Taxotere while eliminating the presence of polysorbate 80 and ethanol, both of which are used to solubilize docetaxel in the Taxotere formulation. The ANX-514 formulation solubilizes docetaxel using oil droplets consists of a combination of non-toxic excipients. Docetaxel is contained within these oil droplets and can be administered intravenously without using detergents as pharmaceutical vehicles. Once in central circulation, the emulsion is metabolized rapidly, leaving chemically-identical active ingredient to exert its cytotoxic effect. ANX-514 may reduce the incidence and severity of hypersensitivity reactions and delay the onset of fluid retention.
Exelbine (vinorelbine injectable emulsion)
Exelbine is an emulsion formulation of the chemotherapy drug vinorelbine. Navelbine, a branded formulation of vinorelbine, is approved in the United States to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer.
In August 2011, the Company received a complete response letter from the Food and Drug Administration (FDA) stating that it could not approve the Exelbine Non Disclosure Agreement (NDA) in its present form and that the bioequivalence study would need to be repeated because the authenticity of the drug products used in the bioequivalence trial could not be verified in accordance with FDA standards. However, the Company elected to discontinue independent development of Exelbine and as of December 31, 2011, the Company was seeking a partner or outside investor for the program to complete the necessary bioequivalence study.
The Company competes with GlaxoSmithKline, Provenge and Pfizer.
Advisors' Opinion:- [By James E. Brumley]
A little over a month ago, owning Mast Therapeutics, Inc. (NYSE: MSTX) was nothing but pure misery. Shares plunged from $0.63 to $0.43 in one day, when details of a dilutive public offering were unveiled. As is so often the case though, the market may have overshot with the selling effort that KO's MSTX. Though putting more shares 'out there' mathematically meant existing shareholders would have to share more of the company's upside with newcomers, what's slowly coming to light is that the inflow of new cash is still more advantageous to those prior shareholders; the company would progress little without it.
- [By Roberto Pedone]
Mast Therapeutics (MSTX), a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. This stock closed up 2.1% 65 cents per share in Thursday's trading session.
Thursday's Range: $0.63-$0.67
52-Week Range: $0.40-$1.10
Thursday's Volume: 1.11 million
Three-Month Average Volume: 1.88 millionFrom a technical perspective, MSTX spiked modestly higher here right above its 50-day moving average of 61 cents per share with decent upside volume. This stock has been trending sideways and consolidating for the last month, with shares moving between 60 cents on the downside and 72 cents on the upside. Shares of MSTX are now starting to push higher and into range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if MSTX manages to clear some near-term overhead resistance levels at 68 to 72 cents per share with high volume.
Traders should now look for long-biased trades in MSTX as long as it's trending above some key near-term support at 60 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.88 million shares. If that breakout materializes soon, then MSTX will set up to re-test or possibly take out its next major overhead resistance levels at 80 to 85 cents per share, or even 93 cents per share.
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:
No comments:
Post a Comment